July 25, 2024Open Access

Theranostics Using MCM-41-Based Mesoporous Silica Nanoparticles: Integrating Magnetic Resonance Imaging and Novel Chemotherapy for Breast Cancer Treatment

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Advanced breast cancer remains a significant oncological challenge, requiring new approaches to improve clinical outcomes. This study investigated an innovative theranostic agent using the MCM-41-NH

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Pires et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5f0a2b6db64358758525e https://doi.org/https://doi.org/10.3390/ijms25158097

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women2003 · 1,863 citations
2Core-triple shells pH-responsive zinc-ferrite nanocomposite: Efficient dual remedy for targeted lung cancer therapy2023 · 6 citations
3Key factor affecting the basicity of mesoporous silicas MCM-41: effect of surfactant extraction time and Si/Al ratio2017 · 29 citations
4Synthesis of Nanoscale Mesoporous Silica Spheres with Controlled Particle Size2002 · 404 citations
5Designing novel anticancer drug release vehicles based on mesoporous functionalized MCM-41 nanoparticles2021 · 41 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo